Federal Science and Public Health Funding Page

Feb. 16, 2022

In the U.S., federal funding fuels the research that drives discovery, spurs innovation, and improves the health of animals, humans, the environment and the economy. Given the diverse nature of microbiology, a number of federal agencies fund these efforts. ASM works to ensure robust, sustained funding for microbiology research across a host of federal agencies. Learn more about how the appropriations process works.

Download Appropriations Factsheet

The Appropriations Process

Graphic of the Appropriations Process
Source: National Science Foundation


FY 2023 Budget Update

The President’s proposed budget for Fiscal Year (FY) 2023 was released March 28, 2022. See below for the suggested funding levels by department and program.

In late July, the House passed along party lines the first set of 6 fiscal year (FY) 2023 spending bills, including the FDA/Agriculture and Energy/Water bills, which fund the U.S. Department of Agriculture research programs and the Department of Energy Office of Science, respectively. 

Congress narrowly averted a government shutdown and cleared a short-term Continuing Resolution (CR) for the President’s desk on September 30, the end of the federal fiscal year. The CR will hold federal departments and agencies at current funding levels through mid-December. CRs have become the norm in recent years, and they serve to keep the government running on “autopilot” until the new spending bills can be passed.
 

Key Elements of the President's Budget

  • National Institutes of Health (NIH) would receive $12.05 billion for Pandemic Preparedness. The Biden Administration requested $5 billion for the new Advanced Research Project Agency for Health (ARPA-H). However, they chose to place ARPA-H within the NIH rather than creating an independent Agency.
  • 2 CDC programs of note would be funded under Pandemic Preparedness: the Domestic and Global Threat Detection at just over $5 billion and Antimicrobial Resistance (AMR) at $1 billion.
  • The National Science Foundation (NSF) would be allocated an overall $10.5 billion in the President’s budget while the U.S. Department of Energy (DOE) Office of Science would receive $7.8 billion.
  • Note: In the wake of COVID-19, there were multiple supplemental funding bills enacted to provide additional, emergency funding in FY 2021 and beyond. These funds primarily have been directed to the NIH's National Institute of Allergy and Infectious Diseases (NIAID), CDC and the Biomedical Advanced Research and Development Authority (BARDA).

National Institutes of Health
 
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
National Institutes of Health $44.9 billion $49 billion $47.5 billion $47.9 billion  
National Institute of Allergy and Infectious Diseases (NIAID) $6.32 billion $6.27 billion $6.64 billion $6.65 billion  

Read ASM testimony to Subcommittee on Labor, Health and Human Services, Education and Related Agencies

Centers for Disease Control and Prevention
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
CDC Overall Budget $8.5 billion $10.67 billion $10.5 billion $10.5 billion  
Emerging and Zoonotic Infectious Disease     $693 million $703 million $799 million $794 million  
Immunization and Respiratory Disease $868 million $1.25 billion $1.08 billion $1.12 billion  
HIV/AIDS, Viral Hepatitis, STI and TB Prevention     $1.35 billion $1.47 billion $1.46 million $1.46 billion  
Global Health     $647 million $748 million $758 million $761 million  
Public Health Preparedness $862 million $842 million $882 million $888 million  

Read ASM testimony to Subcommittee on Labor, Health and Human Services, Education and Related Agencies

National Science Foundation
 
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
National Science Foundation $8.84 billion $10.5 billion $9.63 billion $10.3 billion  

Read ASM testimony to the Subcommittee on Commerce, Justice, Science and Related Agencies

Food and Drug Administration
AGENCY/PROGRAM FY22 ACTUAL  FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
FDA (budget authority) $3.3 billion $3.72 billion $3.64 billion $3.55 billion  

Department of Agriculture
                               
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
National Institute of Food and Agriculture $1.64 billion $1.82 billion $1.77 billion $1.69 billion  
Agricultural Research Service $1.76 billion $1.86 million $1.74 billion $1.76 billion  

Read ASM Testimony to the Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies. 

Department of Energy
                               
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
DOE Office of Science $7.47 billion $7.8 billion $8 billion $8.1 billion  

Read ASM testimony to Subcommittee on Energy and Water Development and Related Agencies. 

Other Agencies and Programs
AGENCY/PROGRAM FY22 ACTUAL FY23 PRES. PROPOSAL HOUSE FY23 SENATE FY23 FY23 ACTUAL
HHS: Public Health and Social Services Emergency Fund (PHSSEF) $3.20 billion $3.82 billion $3.69 billion $3.63 billion  
Biomedical Advanced Research and Development Authority (BARDA) $745 million $828 million $845 million $818 million  
Office of Science, Technology and Policy (OSTP) $6.65 million $7.96 million $7.96 million 7.70 million  
National Oceanic and Atmospheric Administration (NOAA) Research Office $599 million $666 million $699 million $688 million  
U.S. Geological Survey (USGS) $1.39 billion $1.71 billion $1.64 billion $1.52 billion  
Environmental Protection Agency (EPA): Science and Technology $750 million $863 million $873 million $853 million  
National Aeronautics and Space Administration (NASA) Science Directorate $7.6 billion $7.99 billion      

Visit our action alerts page for ways you can advocate for funding for scientific agencies.

Tell Congress to Act on Appropriations


ASM’s Public Policy and Advocacy Team discuss the current atmosphere on Capitol Hill, as well as how decisions made in Washington, D.C. affect your research and the role you can play as an effective advocate.

Author: ASM Advocacy

ASM Advocacy
ASM Advocacy is making it easy and providing opportunities for members to advocate for evidence-based scientific policy.